Found: 6
Select item for more details and to access through your institution.
1448-P: Enhanced Liver Fibrosis (ELF) Test Can Accurately Predict Advanced Fibrosis in Patients with Type 2 Diabetes and Nonalcoholic Fatty Liver Disease (NAFLD).
- Published in:
- Diabetes, 2020, v. 69, p. N.PAG, doi. 10.2337/db20-1448-P
- By:
- Publication type:
- Article
The impact of variants and vaccination on the mortality and resource utilization of hospitalized patients with COVID-19.
- Published in:
- BMC Infectious Diseases, 2022, v. 22, n. 1, p. 1, doi. 10.1186/s12879-022-07657-z
- By:
- Publication type:
- Article
The combination of the enhanced liver fibrosis and FIB‐4 scores to determine significant fibrosis in patients with nonalcoholic fatty liver disease.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2023, v. 57, n. 12, p. 1417, doi. 10.1111/apt.17472
- By:
- Publication type:
- Article
Anti-adipocyte antibody response in patients with non-alcoholic fatty liver disease.
- Published in:
- Journal of Gastroenterology & Hepatology, 2015, v. 30, n. 5, p. 900, doi. 10.1111/jgh.12856
- By:
- Publication type:
- Article
A single non-invasive model to diagnose non-alcoholic fatty liver disease ( NAFLD) and non-alcoholic steatohepatitis ( NASH).
- Published in:
- Journal of Gastroenterology & Hepatology, 2014, v. 29, n. 12, p. 2006, doi. 10.1111/jgh.12665
- By:
- Publication type:
- Article
Performance of the Enhanced Liver Fibrosis Test to Estimate Advanced Fibrosis Among Patients With Nonalcoholic Fatty Liver Disease.
- Published in:
- JAMA Network Open, 2021, v. 4, n. 9, p. e2123923, doi. 10.1001/jamanetworkopen.2021.23923
- By:
- Publication type:
- Article